SciELO - Scientific Electronic Library Online

 
vol.15 número3Histiocitosis de células mixtas: Reporte de un casoLupus de inicio tardío neurológico asociado a accidente cerebrovascular en el adulto mayor: Reporte de caso y revisión sistemática rápida índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo

versão impressa ISSN 2225-5109versão On-line ISSN 2227-4731

Resumo

FLORES-LAZO, Lucía B.; OLIVERA-RUIZ, Rubén  e  VENCES, Miguel A.. Management of anti-NMDAR encephalitis with Rituximab: Case report in a Public Hospital of Lima, Peru. Rev. Cuerpo Med. HNAAA [online]. 2022, vol.15, n.3, pp.439-443.  Epub 30-Set-2022. ISSN 2225-5109.  http://dx.doi.org/10.35434/rcmhnaaa.2022.153.1324.

Introduction: Autoimmune encephalitis comprises a wide spectrum of immunological disorders, among them anti-NMDAR is the most frequent. The management of this pathology is complex due to multiple circumstances. Case report: A 19-year-old woman who started a subacute clinical picture with associated behavioral and neurological disorder: hallucinations, heteroaggressiveness, akinetic mutism, epileptic seizures, orofacial dyskinesias, fever and reported transient cardiac arrhythmia. MRI was normal, EEG recorded delta brush waves, CSF and serum studies were negative for secondary causes. Treatment was started with Acyclovir, an anti-crisis drug, and psychotropic drugs, later methylprednisolone with immunoglobulin was started without a satisfactory response. She starts treatment with Rituximab presenting a favorable response. The CSF panel was positive for NMDA. Control with progressive de-escalation of anti-crisis medications and psychotropic drugs is indicated. Conclusion: It is important to recognize early the clinical manifestations of this entity in order to carry out timely management that could improve the prognosis.

Palavras-chave : Encephalitis; Antibodies, Antinuclear; Encefalitis Antirreceptor N-Metil-D-Aspartato; Peru.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )